| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |